Lifeboat Foundation

Taking aim at one of the best business models of all time.

A research team led by Dr. Serge Krasnokutski from the Astrophysics Laboratory at the Max Planck Institute for Astronomy at the University of Jena had already demonstrated that simple peptides can form on cosmic dust particles. However, it was previously assumed that this would not be possible if molecular ice, which covers the dust particle, contains water—which is usually the case.

Now the team, in collaboration with the University of Poitiers, France, has discovered that the presence of water molecules is not a major obstacle for the formation of peptides on such dust particles. The researchers report on their finding in the journal Science Advances.

Chemistry in the icy vacuum “We have replicated conditions similar to those in outer space in a vacuum chamber, also adding substances that occur in so-called molecular clouds,” explains Krasnokutski. These substances include ammonia, atomic carbon, and carbon monoxide. “Thus, all the chemical elements needed for simple peptides are present,” adds the physicist.

The natural vein structure found within leaves—which has inspired the structural design of porous materials that can maximize mass transfer—could unlock improvements in energy storage, catalysis, and sensing thanks to a new twist on a century-old biophysical law.

Nanoscale materials present us with astonishing chemical and physical properties that help materialize applications such as single molecular sensing and minimally invasive photothermal therapy—which were once just theories—into reality.

Nanostructured high entropy alloys—metals made from a chaotic mix of several different elements—show a lot of promise for use in industries such as aerospace and automotive because of their strength and stability at high temperatures compared with regular metals.

Drug delivery researchers at Oregon State University have developed a device with the potential to improve gene therapy for patients with inherited lung diseases such as cystic fibrosis.

In the early 20th century, the development of a catalyst for ammonia synthesis by the Haber-Bosch method took more than 10,000 experiments before it was successful. The development of new materials is a time-consuming and costly process from design to commercialization.

While we usually think of disorder as a bad thing, a team of materials science researchers led by Rohan Mishra, from Washington University in St. Louis, and Jayakanth Ravichandran, from the University of Southern California, have revealed that—when it comes to certain crystals—a little structural disorder might have big impacts on useful optical properties.

Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have developed a nanoparticle that can penetrate the blood-brain barrier. Their goal is to kill primary breast cancer tumors and brain metastases in one treatment, and their research shows the method can shrink breast and brain tumors in laboratory studies.